BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9463603)

  • 1. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex.
    Biver F; Wikler D; Lotstra F; Damhaut P; Goldman S; Mendlewicz J
    Br J Psychiatry; 1997 Nov; 171():444-8. PubMed ID: 9463603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.
    Meltzer CC; Price JC; Mathis CA; Greer PJ; Cantwell MN; Houck PR; Mulsant BH; Ben-Eliezer D; Lopresti B; DeKosky ST; Reynolds CF
    Am J Psychiatry; 1999 Dec; 156(12):1871-8. PubMed ID: 10588399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
    Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
    Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.
    Sadzot B; Lemaire C; Maquet P; Salmon E; Plenevaux A; Degueldre C; Hermanne JP; Guillaume M; Cantineau R; Comar D
    J Cereb Blood Flow Metab; 1995 Sep; 15(5):787-97. PubMed ID: 7673371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbance of serotonin 5HT2 receptors in remitted patients suffering from hereditary depressive disorder.
    Larisch R; Klimke A; Mayoral F; Hamacher K; Herzog HR; Vosberg H; Tosch M; Gaebel W; Rivas F; Coenen HH; Müller-Gärtner HW
    Nuklearmedizin; 2001 Aug; 40(4):129-34. PubMed ID: 11556203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study.
    Meyer JH; Kapur S; Houle S; DaSilva J; Owczarek B; Brown GM; Wilson AA; Kennedy SH
    Am J Psychiatry; 1999 Jul; 156(7):1029-34. PubMed ID: 10401447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study.
    Biver F; Lotstra F; Monclus M; Dethy S; Damhaut P; Wikler D; Luxen A; Goldman S
    Nucl Med Biol; 1997 May; 24(4):357-60. PubMed ID: 9257335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone.
    Yatham LN; Liddle PF; Dennie J; Shiah IS; Adam MJ; Lane CJ; Lam RW; Ruth TJ
    Arch Gen Psychiatry; 1999 Aug; 56(8):705-11. PubMed ID: 10435604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography.
    Mintun MA; Sheline YI; Moerlein SM; Vlassenko AG; Huang Y; Snyder AZ
    Biol Psychiatry; 2004 Feb; 55(3):217-24. PubMed ID: 14744461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
    Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH
    Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man.
    Larisch R; Klimke A; Hamacher K; Henning U; Estalji S; Hohlfeld T; Vosberg H; Tosch M; Gaebel W; Coenen HH; Müller-Gärtner HW
    Behav Brain Res; 2003 Feb; 139(1-2):21-9. PubMed ID: 12642173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.
    Wong DF; Lever JR; Hartig PR; Dannals RF; Villemagne V; Hoffman BJ; Wilson AA; Ravert HT; Links JM; Scheffel U
    Synapse; 1987; 1(5):393-8. PubMed ID: 2905532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin.
    van Dyck CH; Tan PZ; Baldwin RM; Amici LA; Garg PK; Ng CK; Soufer R; Charney DS; Innis RB
    J Nucl Med; 2000 Feb; 41(2):234-41. PubMed ID: 10688105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans.
    Price JC; Lopresti BJ; Meltzer CC; Smith GS; Mason NS; Huang Y; Holt DP; Gunn RN; Mathis CA
    Synapse; 2001 Jul; 41(1):11-21. PubMed ID: 11354009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography.
    Sheline YI; Mintun MA; Barch DM; Wilkins C; Snyder AZ; Moerlein SM
    Neuropsychopharmacology; 2004 Dec; 29(12):2235-41. PubMed ID: 15367923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging.
    Kapur S; Jones C; DaSilva J; Wilson A; Houle S
    Nucl Med Commun; 1997 May; 18(5):395-9. PubMed ID: 9194079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT2 receptor binding on blood platelets as a state dependent marker in major affective disorder.
    Biegon A; Essar N; Israeli M; Elizur A; Bruch S; Bar-Nathan AA
    Psychopharmacology (Berl); 1990; 102(1):73-5. PubMed ID: 2392511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain serotonin2 receptors in major depression: a positron emission tomography study.
    Yatham LN; Liddle PF; Shiah IS; Scarrow G; Lam RW; Adam MJ; Zis AP; Ruth TJ
    Arch Gen Psychiatry; 2000 Sep; 57(9):850-8. PubMed ID: 10986548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.